Trichuris suis ova in relapsing-remitting multiple sclerosis and clinically isolated syndrome (TRIOMS): study protocol for a randomized controlled trial.
about
Identifying the immunomodulatory components of helminthsKv1.3 channel-blocking immunomodulatory peptides from parasitic worms: implications for autoimmune diseasesHelminth/Parasite Treatment of Multiple SclerosisTrichuris suis induces human non-classical patrolling monocytes via the mannose receptor and PKC: implications for multiple sclerosis.Somatic extracts of Marshallagia marshalli downregulate the Th2 associated immune responses in ovalbumin-induced airway inflammation in BALB/c mice.The status of evolutionary medicine education in North American medical schoolsAdjuvant treatment with the bacterial lysate (OM-85) improves management of atopic dermatitis: A randomized study.A parasite-derived 68-mer peptide ameliorates autoimmune disease in murine models of Type 1 diabetes and multiple sclerosis.Anti-inflammatory Potentials of Excretory/Secretory (ES) and Somatic Products of Marshallagia marshalli on Allergic Airway Inflammation in BALB/c Mice.Microorganism-induced suppression of allergic airway disease: novel therapies on the horizon?Mast cells: new therapeutic target in helminth immune modulation.Failed, interrupted and inconclusive trials on relapsing multiple sclerosis treatment: update 2010-2015.Nematodes and human therapeutic trials for inflammatory disease.Trichuris suis ova therapy in relapsing multiple sclerosis is safe but without signals of beneficial effect.Panning for molecular gold in whipworm genomes.Novel Therapeutics for Multiple Sclerosis Designed by Parasitic Worms.Therapeutic potential of larval excretory/secretory proteins of the pig whipworm Trichuris suis in allergic disease.Is the hygiene hypothesis relevant for the risk of multiple sclerosis?Probiotics for the Control of Helminth Zoonosis.A comprehensive analysis of the faecal microbiome and metabolome of Strongyloides stercoralis infected volunteers from a non-endemic area
P2860
Q26823533-E1781986-B864-4E0E-8683-D6FF01889C89Q27684056-BB2882FD-305F-4B6E-BAAA-3D6530E31AACQ29039518-92FF905C-72EF-4590-8904-2EA143B68CFAQ30658854-B3D2C697-B920-48CE-A0CE-F795737398A1Q33668037-D25DF06D-40F7-45E4-8844-1C2D3711A8B9Q35166498-AC1F8B9B-D961-411F-B065-90F028DE8260Q36319745-61604BC3-B63A-4F38-B3C8-4212C3E809D3Q37435137-D9ECC216-56A1-434A-89B0-47241236FCA2Q37597018-D42E02CC-5901-4279-9A7A-37640ECF41EFQ38241379-7DCBB80B-8B80-480A-8623-2B06E4AD68A7Q38636165-F32A2D4E-65A8-4AEC-96AD-041EFF19F559Q38801807-85F2D23C-8A41-4D1F-BD42-AABB02EC9CAEQ39039247-D06032E7-C1C6-4416-9C39-2EB1ED2BED7FQ41474442-425EB2B7-31FB-4D93-BA2C-2B11D3C7D618Q44044415-1E5AB7D8-4F77-49E0-8D4B-4DB33C4B7FCAQ45842759-1343E2C0-6B22-45D7-BE86-199110427533Q46990784-BD3119C0-0F0F-4098-9E21-EE1A61A2B911Q47600994-0A2CF177-18A6-44DB-A162-C084FD154A7EQ52581732-07EDAB51-03BA-4ED6-A098-C9B6310FE570Q57799940-FC1B0E1E-3BE2-4608-AD1F-85036BD01338
P2860
Trichuris suis ova in relapsing-remitting multiple sclerosis and clinically isolated syndrome (TRIOMS): study protocol for a randomized controlled trial.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Trichuris suis ova in relapsin ...... a randomized controlled trial.
@en
type
label
Trichuris suis ova in relapsin ...... a randomized controlled trial.
@en
prefLabel
Trichuris suis ova in relapsin ...... a randomized controlled trial.
@en
P2093
P2860
P356
P1433
P1476
Trichuris suis ova in relapsin ...... a randomized controlled trial.
@en
P2093
Berit Rosche
Friedemann Paul
Jan-Markus Dörr
Stephanie Ohlraun
P2860
P2888
P356
10.1186/1745-6215-14-112
P577
2013-04-25T00:00:00Z
P5875
P6179
1001185550